Morana Jovan-Embiricos

Companies

• Kalaris Therapeutics, Inc.Board member Jul 30, 2020 to now¹
• Cullinan OncologyBoard member Jan 7, 2021 to Mar 25, 2022²
• TCR2 THERAPEUTICS INC.Board member Feb 13, 2019 to Feb 21, 2019³
• Radius Health, Inc.Board member May 3, 2013 to Jan 20, 2015⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• KTKalaris Therapeutics, Inc. KLRS16,774,963 shares⁵$32.0M at $1.91Jun 7, 2024
• COCullinan Oncology CGEM1,463,766 shares⁶$20.0M at $13.68Aug 4, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 6, 2024Granted 35,000 shares of Kalaris Therapeutics, Inc.⁵
• May 11, 2023Granted 35,000 shares of Kalaris Therapeutics, Inc.⁷
• Aug 4, 2022Sold 25,989 shares at $14.31 of Cullinan Oncology⁶
• Aug 3, 2022Sold 19,129 shares at $14.24 of Cullinan Oncology⁶
• Aug 2, 2022Sold 4,792 shares at $14.10 of Cullinan Oncology⁶
• Jul 28, 2022Granted 3,253,796 shares at $4.61 of Kalaris Therapeutics, Inc.⁸
• Jul 28, 2022Granted 867,678 shares at $4.61 of Kalaris Therapeutics, Inc.⁸
• Jul 28, 2022Granted 1,393,874 shares at $4.61 of Kalaris Therapeutics, Inc.⁸
• Jul 28, 2022Granted 1,626,898 shares at $4.61 of Kalaris Therapeutics, Inc.⁸
• Jul 28, 2022Granted 325,379 shares at $4.61 of Kalaris Therapeutics, Inc.⁸
• Jul 28, 2022Granted 684,622 shares at $4.61 of Kalaris Therapeutics, Inc.⁸
• Jun 24, 2022Shares withheld for tax 45,078 shares at $13.39 of Cullinan Oncology⁹
• Jun 24, 2022Exercised options 35,529 shares at $4.30 of Cullinan Oncology⁹
• Jun 24, 2022Exercised options 104,845 shares at $4.30 of Cullinan Oncology⁹
• Jan 11, 2022Other 1,187,734 shares of Cullinan Oncology¹⁰
• Nov 10, 2021Sold 120 shares at $24.77 of Kalaris Therapeutics, Inc.¹¹
• Nov 10, 2021Sold 680 shares at $24.77 of Kalaris Therapeutics, Inc.¹¹
• Nov 9, 2021Sold 572 shares at $24.79 of Kalaris Therapeutics, Inc.¹²
• Nov 9, 2021Sold 3,243 shares at $24.79 of Kalaris Therapeutics, Inc.¹²
• Nov 5, 2021Sold 1,257 shares at $24.80 of Kalaris Therapeutics, Inc.¹²
• Nov 5, 2021Sold 7,124 shares at $24.80 of Kalaris Therapeutics, Inc.¹²
• Oct 27, 2021Sold 330 shares at $24.78 of Kalaris Therapeutics, Inc.¹³
• Oct 27, 2021Sold 1,870 shares at $24.78 of Kalaris Therapeutics, Inc.¹³
• Oct 25, 2021Sold 1,165 shares at $24.82 of Kalaris Therapeutics, Inc.¹⁴
• Oct 25, 2021Sold 6,604 shares at $24.82 of Kalaris Therapeutics, Inc.¹⁴